PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Erbb2 4,536 Target Target EGF 27,487 513 0.05 -0.93 0.11 0.72
Erbb2 4,536 Target Target Cytokeratin 8 587 2 0.00 -1.00 0.00 0.61
Erbb2 4,536 Target Target Platelet Activating Factor 9,915 1 0.00 -1.00 0.00 0.52
Erbb2 4,536 Target Target Toll-Like Receptor 2 2,174 1 0.00 -1.00 0.00 0.56
Erbb2 4,536 Target Disease Disabilities 28,757 1 0.00 -1.00 0.00 0.49
Erbb2 4,536 Target Target ERBB4 994 461 0.22 -0.69 0.46 0.83
Erbb2 4,536 Target Disease Testicular Cancer 4,459 2 0.00 -1.00 0.00 0.56
Erbb2 4,536 Target Target Epiregulin 291 14 0.01 -0.97 0.05 0.69
Erbb2 4,536 Target Target BRK 236 3 0.00 -0.99 0.01 0.64
ApoE4 1,525 Target Disease Prostate Cancer 71,064 1 0.00 -1.00 0.00 0.50
AMY2B 21 Target Disease Psoriasis 26,882 1 0.00 -0.98 0.05 0.60
AMY2B 21 Target Target Alpha-Amylase 7,171 9 0.02 -0.76 0.43 0.70
CD14 9,941 Target Target Arachidonate 5-Lipoxygenase 170 1 0.00 -1.00 0.01 0.59
CD14 9,941 Target Target CXCL9 1,016 16 0.01 -0.99 0.02 0.64
CD14 9,941 Target Disease HIV/AIDS 20,397 5 0.00 -1.00 0.00 0.53
CD14 9,941 Target Disease Neutropenia 25,934 19 0.00 -1.00 0.00 0.56
CD14 9,941 Target Disease Hepatitis 163,842 138 0.00 -0.99 0.01 0.57
CD14 9,941 Target Target Collagen 138,882 170 0.00 -0.99 0.02 0.58
CD14 9,941 Target Disease Keratitis 10,599 4 0.00 -1.00 0.00 0.54
CD14 9,941 Target Target EG-VEGF 63 1 0.00 -0.99 0.02 0.61
CD14 9,941 Target Disease Cholesterol 182,390 111 0.00 -0.99 0.01 0.55
CD14 9,941 Target Disease Retinitis 9,116 1 0.00 -1.00 0.00 0.50
CD14 9,941 Target Disease Rheumatoid Arthritis 78,952 249 0.01 -0.99 0.03 0.62
CD14 9,941 Target Disease Relapsing Remitting Multiple Sclerosis 2,115 12 0.00 -1.00 0.01 0.62
CD14 9,941 Target Target CXCL10/IP-10 114 1 0.00 -1.00 0.01 0.60
CD14 9,941 Target Target Bivalirudin 891 1 0.00 -1.00 0.00 0.56
CD14 9,941 Target Disease Hyperprolactinemia 4,112 1 0.00 -1.00 0.00 0.52
CD14 9,941 Target Disease Diverticulitis 4,735 1 0.00 -1.00 0.00 0.52
CD14 9,941 Target Disease Sarcoidosis 19,176 35 0.00 -1.00 0.00 0.59
CD14 9,941 Target Disease Malaria 56,215 27 0.00 -1.00 0.00 0.55
CD14 9,941 Target Target CD95 4,266 33 0.01 -0.99 0.01 0.64
CD14 9,941 Target Disease Bursitis 2,133 2 0.00 -1.00 0.00 0.56
CD14 9,941 Target Target Cox-2 21,583 56 0.00 -1.00 0.01 0.61
CD14 9,941 Target Disease Dyslipidemia 15,225 9 0.00 -1.00 0.00 0.55
CD14 9,941 Target Target Cytokeratin 8 587 1 0.00 -1.00 0.00 0.57
CD14 9,941 Target Target Platelet Activating Factor 9,915 25 0.00 -1.00 0.00 0.61
CD14 9,941 Target Target Toll-Like Receptor 2 2,174 204 0.04 -0.94 0.09 0.73
CD14 9,941 Target Target BMP-4 1,255 3 0.00 -1.00 0.00 0.58
CD14 9,941 Target Target Alpha-1 AntiChymotrypsin 1,460 5 0.00 -1.00 0.00 0.59
CD14 9,941 Target Target Epiregulin 291 1 0.00 -1.00 0.00 0.58
CD14 9,941 Target Target Sphingomyelinase 3,060 7 0.00 -1.00 0.00 0.59
CD14 9,941 Target Target CD146 729 38 0.01 -0.97 0.05 0.68
CD14 9,941 Target Drug Abacavir 1,496 2 0.00 -1.00 0.00 0.57
CD14 9,941 Target Disease Gram Negative Bacterial Infection 246 12 0.01 -0.97 0.05 0.66
CD14 9,941 Target Target C7 7,027 1 0.00 -1.00 0.00 0.51
CD14 9,941 Target Disease Migraine 24,200 3 0.00 -1.00 0.00 0.51
CD14 9,941 Target Target CCL3 1,427 26 0.01 -0.99 0.02 0.65
CD14 9,941 Target Disease Leishmaniasis 15,049 25 0.00 -1.00 0.00 0.59
CD14 9,941 Target Disease Leukemias 14,152 91 0.01 -0.99 0.01 0.65
CD14 9,941 Target Disease Menopause 19,680 6 0.00 -1.00 0.00 0.53